80 related articles for article (PubMed ID: 30051681)
1. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.
Salem A; Wu Y; Albarracin CT; Middleton LP; Kalhor N; Peng Y; Huang X; Aung PP; Chen H; Sahin AA; Ding Q
Hum Pathol; 2024 Mar; 145():42-47. PubMed ID: 38262580
[TBL] [Abstract][Full Text] [Related]
3. AKT3 drives adenoid cystic carcinoma development in salivary glands.
Zboray K; Mohrherr J; Stiedl P; Pranz K; Wandruszka L; Grabner B; Eferl R; Moriggl R; Stoiber D; Sakamoto K; Wagner KU; Popper H; Casanova E; Moll HP
Cancer Med; 2018 Feb; 7(2):445-453. PubMed ID: 29282901
[TBL] [Abstract][Full Text] [Related]
4. Par-1b is required for morphogenesis and differentiation of myoepithelial cells during salivary gland development.
Gervais EM; Sequeira SJ; Wang W; Abraham S; Kim JH; Leonard D; DeSantis KA; Larsen M
Organogenesis; 2016 Oct; 12(4):194-216. PubMed ID: 27841695
[TBL] [Abstract][Full Text] [Related]
5. Primary thymic adenoid cystic carcinoma with high-grade transformation: A clinicopathological and immunohistochemical analysis of 4 cases.
Weissferdt A; Moran CA
Pathol Res Pract; 2024 Jul; 259():155356. PubMed ID: 38810375
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible tissue scaffold compliance promotes salivary gland morphogenesis and differentiation.
Peters SB; Naim N; Nelson DA; Mosier AP; Cady NC; Larsen M
Tissue Eng Part A; 2014 Jun; 20(11-12):1632-42. PubMed ID: 24410370
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma.
Parikh AS; Wizel A; Davis D; Lefranc-Torres A; Rodarte-Rascon AI; Miller LE; Emerick KS; Varvares MA; Deschler DG; Faquin WC; Aster JC; Lin DT; Bernstein BE; Drier Y; Puram SV
Cell Rep; 2022 Nov; 41(9):111743. PubMed ID: 36450256
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of laminin expression in adenoid cystic carcinoma.
Anupriya S; Mahesh P; Sharada P; Swaminathan U; Nagamalini B; Hosthor SS
J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S26-31. PubMed ID: 25364175
[TBL] [Abstract][Full Text] [Related]
9. Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Systematic Review and Meta-Analysis of Clinical Characteristics and Management Strategies.
Jaber MA; Hassan M; Ingafou M; Elameen AM
J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202273
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Histopathological Parameters for Salivary Gland Adenoid Cystic Carcinoma.
de Morais EF; de Farias Morais HG; de Almeida Freitas R; Coletta RD
Dent J (Basel); 2023 Nov; 11(11):. PubMed ID: 37999026
[TBL] [Abstract][Full Text] [Related]
11. Short histological kaleidoscope - recent findings in histology. Part III.
Constantin AM; Mihu CM; Boşca AB; Melincovici CS; Mărginean MV; Jianu EM; Onofrei MM; Micu CM; Alexandru BC; Sufleţel RT; Moldovan IM; Coneac A; Crintea A; Ştefan RA; Ştefan PA; Djouini A; Şovrea AS
Rom J Morphol Embryol; 2023; 64(2):115-133. PubMed ID: 37518868
[TBL] [Abstract][Full Text] [Related]
12. Adenoid Cystic Carcinoma of Salivary Glands: A Ten-Year Review and an Assessment of the Current Management, Surgery, Radiotherapy, and Chemotherapy.
Saleh E; Ukwas A
Int J Otolaryngol; 2023; 2023():7401458. PubMed ID: 37159817
[TBL] [Abstract][Full Text] [Related]
13. Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts.
Mollah F; Varamini P
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944738
[TBL] [Abstract][Full Text] [Related]
14. Proliferative Activity of Myoepithelial Cells in Normal Salivary Glands and Adenoid Cystic Carcinomas Based on Double Immunohistochemical Labeling.
Alali F; Kochaji N
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1965-1970. PubMed ID: 30051681
[TBL] [Abstract][Full Text] [Related]
15. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
16. Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study.
Morinaga S; Nakajima T; Shimosato Y
Hum Pathol; 1987 Dec; 18(12):1218-26. PubMed ID: 2824327
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical investigation of vimentin, neuron-specific enolase, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenoid cystic carcinoma of the salivary gland.
Takahashi H; Tsuda N; Fujita S; Tezuka F; Okabe H
Acta Pathol Jpn; 1990 Sep; 40(9):655-64. PubMed ID: 2175537
[TBL] [Abstract][Full Text] [Related]
18. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis.
Chen JC; Gnepp DR; Bedrossian CW
Oral Surg Oral Med Oral Pathol; 1988 Mar; 65(3):316-26. PubMed ID: 2451197
[TBL] [Abstract][Full Text] [Related]
19. Myoepithelial carcinoma of the lung: a review.
Rosen LE; Singh RI; Vercillo M; Gattuso P
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):397-401. PubMed ID: 25517870
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
